Persistence of the Immune Response to an Intramuscular Bivalent (GI.1/GII.4) Norovirus Vaccine in Adults.
Saved in:
| Title: | Persistence of the Immune Response to an Intramuscular Bivalent (GI.1/GII.4) Norovirus Vaccine in Adults. |
|---|---|
| Authors: | Leroux-Roels G; Center for Vaccinology (CEVAC), Ghent University and University Hospital, 9000 Ghent, Belgium., Atmar RL; Departments of Medicine and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA., Cramer JP; Clinical Development, Takeda Pharmaceuticals International AG, Farman Strasse 11, Opfikon, 8152 Zurich, Switzerland.; Clinical Development, Coalition for Epidemic Preparedness Innovations (CEPI), Gibbs Building, 215 Euston Road, London NW1 2BE, UK., Escudero I; Clinical Development, Takeda Pharmaceuticals International AG, Farman Strasse 11, Opfikon, 8152 Zurich, Switzerland.; Clinical Development, Takeda Vaccines, 75 Sidney St., Cambridge, MA 02139, USA., Borkowski A; Clinical Development, Takeda Pharmaceuticals International AG, Farman Strasse 11, Opfikon, 8152 Zurich, Switzerland.; HilleVax AG, Boulevard Lilienthal 42, Opfikon, 8152 Zurich, Switzerland. |
| Source: | Vaccines [Vaccines (Basel)] 2025 Jan 17; Vol. 13 (1). Date of Electronic Publication: 2025 Jan 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2076-393X |
|---|---|
| DOI: | 10.3390/vaccines13010082 |
